CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line

被引:72
|
作者
Porcile, C
Bajetto, A
Barbero, S
Pirani, P
Schettini, G
机构
[1] Ctr Biotecnol Avanzate, Serv Pharmacol & Neurosci, IST, Natl Inst Canc Res, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Sect, I-16132 Genoa, Italy
关键词
stromal cell-derived factor-1; CXCR4 chemokine receptor; ovarian cancer cell proliferation; mitogen-activated protein kinase;
D O I
10.1196/annals.1329.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines are a family of proteins that have pleiotropic biological effects. They are well known to regulate the recruitment and trafficking of leukocytes to sites of inflammation. Chemokines are grouped into four classes based on the positions of key cysteine residues: C, CC, CXC, and CX3C. Stromal cell-derived factor-1 (SDF-1), the ligand of the CXCR4 receptor, is a CXC chemokine and is a highly conserved gene. Ovarian cancer typically disseminates widely in the abdomen, a characteristic that limits curative therapy. The mechanisms that promote ovarian cancer proliferation are incompletely understood. We studied a human ovarian adenocarcinoma cell line (OC 314) and investigated the role of CXCR4 activation by SDF-1 in human ovarian cancer. We demonstrate that CXCR4 and SDF-1 mRNA are expressed in OC 314. We show that SDF-1 alpha induces proliferation in ovarian cancer cells in a dose-dependent manner. Moreover, we demonstrate that the SDF-1-dependent proliferation correlates to the phosphorylation and activation of extracellular signal-regulated kinases (ERK)1/2, which in turn are correlated to epidermal growth factor (EGF) receptor transactivation. In fact,AG1478, a specific inhibitor of the EGF receptor kinase, blocked both SDF-1 alpha-dependent proliferation and ERK1/2 activation.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [21] Schizandrin A induces non-small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation
    Zhu, Linhai
    Wang, Yanye
    Huang, Xuhua
    Liu, Xide
    Ye, Bo
    He, Yi
    Yu, Haojie
    Lv, Wang
    Wang, Luming
    Hu, Jian
    [J]. CANCER MEDICINE, 2024, 13 (02):
  • [22] Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness
    Matteucci, E
    Locati, M
    Desiderio, MA
    [J]. EXPERIMENTAL CELL RESEARCH, 2005, 310 (01) : 176 - 185
  • [23] Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor
    Buteau, J
    Foisy, S
    Joly, E
    Prentki, M
    [J]. DIABETES, 2003, 52 (01) : 124 - 132
  • [24] Epidermal growth factor receptor blockers for the treatment of ovarian cancer
    Haldar, Krishnayan
    Gaitskell, Kezia
    Bryant, Andrew
    Nicum, Shibani
    Kehoe, Sean
    Morrison, Jo
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10):
  • [25] Epidermal growth factor receptor blockers for the treatment of ovarian cancer
    Morrison, Jo
    Thoma, Clemens
    Goodall, Richard J.
    Lyons, Thomas J.
    Gaitskell, Kezia
    Wiggans, Alison J.
    Bryant, Andrew
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
  • [26] Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor
    Yang, SX
    Chen, JH
    Jiang, XF
    Wang, QL
    Chen, ZQ
    Zhao, W
    Feng, YH
    Xin, R
    Shi, JQ
    Bian, XW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (02) : 523 - 528
  • [27] Photonic modulation of epidermal growth factor receptor halts receptor activation and cancer cell migration
    Botelho, Claudia M.
    Goncalves, Odete
    Marques, Rogerio
    Thiagarajan, Viruthachalam
    Vorum, Henrik
    Gomes, Andreia C.
    Neves-Petersen, Maria Teresa
    [J]. JOURNAL OF BIOPHOTONICS, 2018, 11 (09)
  • [28] Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer
    Dewan, M. Z.
    Ahmed, S.
    Iwasaki, Y.
    Ohba, K.
    Toi, M.
    Yamamoto, N.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (06) : 273 - 276
  • [29] CD133 AND CXCR4 EXPRESSION IN OVARIAN CANCER CELL LINEs
    Cioffi, M.
    Camerlingo, R.
    Consales, C.
    D'Alterio, C.
    Greggi, S.
    Pignata, S.
    Castello, G.
    Pirozzi, G.
    Scala, S.
    [J]. CYTOMETRY PART A, 2010, 77A (02) : 194 - 194
  • [30] Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line
    Meng Wang
    Patrick Maier
    Frederik Wenz
    Frank Anton Giordano
    Carsten Herskind
    [J]. Journal of Neuro-Oncology, 2013, 115 : 323 - 331